Literature DB >> 9472765

Malignant airway obstruction: recognition and management.

K Chen1, J Varon, O C Wenker.   

Abstract

Malignant airway obstruction affects up to 80,000 patients annually, many of whom will present acutely to the emergency department (ED). This clinical entity should be sought in any patient presenting to the ED with increasing shortness of breath, recurrent chest infections, hemoptysis, and an inability to lie flat. Interventions suggested in malignant airway obstruction include: maintenance of spontaneous ventilation by avoiding respiratory depressing sedation, muscle relaxants or narcotics; changes in patient's position; avoidance of general anesthesia and positive pressure ventilation, if possible; placement of endotracheal tube beyond the level of obstruction; radiotherapy; corticosteroids; availability of helium-oxygen mixtures, cardiopulmonary bypass, or extracorporeal membrane oxygenation. If time allows, further diagnostic studies will be of assistance in assessing the best therapy before definitive intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9472765     DOI: 10.1016/s0736-4679(97)00245-x

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

1.  A Concentric Tube Robot System for Rigid Bronchoscopy: A Feasibility Study on Central Airway Obstruction Removal.

Authors:  Joshua B Gafford; Scott Webster; Neal Dillon; Evan Blum; Richard Hendrick; Fabien Maldonado; Erin A Gillaspie; Otis B Rickman; S Duke Herrell; Robert J Webster
Journal:  Ann Biomed Eng       Date:  2019-07-24       Impact factor: 3.934

2.  Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.

Authors:  Mark D Williams; Lee Ann Braun; Liesl M Cooper; Joseph Johnston; Richard V Weiss; Rebecca L Qualy; Walter Linde-Zwirble
Journal:  Crit Care       Date:  2004-07-05       Impact factor: 9.097

3.  Bronchial obstruction by tumor embolus of contralateral lung during pneumonectomy: report of a case.

Authors:  Dong Kyu Lee; Heezoo Kim; Sang Ho Lim; Young Ho Choi; Hyun Koo Kim
Journal:  J Cardiothorac Surg       Date:  2013-02-19       Impact factor: 1.637

4.  A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.

Authors:  S H Ahmedzai; E Laude; A Robertson; G Troy; V Vora
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.